文献速递肝病消化道肿瘤与早癌

超声与简化MRI在NAFLD肝硬化患者HCC筛查中最佳检查效果的比较:一项前瞻性研究

Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study.
PubMed 文献 · Aliment Pharmacol Ther · 2022-02-28

这项前瞻性多中心研究纳入54例NAFLD肝硬化患者,对比超声与钆塞酸增强肝胆期简化MRI(AMRI)的肝脏可视化评分。超声严重可视化受限者19例(35%),AMRI为10例(19%),p<0.0001;肥胖是超声严重受限的独立预测因素(OR 5.1)。作者认为超声评估不佳时可考虑AMRI用于HCC筛查。

要点

  • NAFLD肝硬化患者中,超声严重可视化受限占35%,AMRI占19%,差异有统计学意义。
  • 超声下肝脏可视化不足90%者占17%,AMRI仅占2%。

核心结论

  • 超过三分之一的NAFLD肝硬化参与者超声筛查HCC时存在严重可视化受限,而AMRI为六分之一;作者建议所有临床研究应报告超声充分性,当超声欠佳时可考虑AMRI用于HCC筛查。

研究设计与样本

  • 前瞻性多中心研究,连续纳入54例NAFLD肝硬化且有HCC监测临床指征的参与者(67%为女性),同期接受超声和钆塞酸增强肝胆期简化MRI(AMRI)检查。

主要发现

  • 平均(±标准差)年龄63.3岁(±8.4),体重指数32.0 kg/m2(±6.0)。
  • 超声严重可视化受限(可视化评分C)19例(35%),AMRI 10例(19%),p<0.0001。
  • 超声下肝脏可视化不足90%者9例(17%),AMRI仅1例(2%),p<0.0001。
  • 调整年龄、性别和种族后,肥胖是超声严重可视化受限的强独立预测因素(OR 5.1,CI 1.1-23.1,p=0.03)。

关键数值与推荐

  • 主要结局为严重肝脏可视化受限(可视化评分C)的影像检查比例,在超声与AMRI之间头对头比较。

临床怎么用

  • 作者建议所有临床研究应报告超声充分性,当超声欠佳时可考虑AMRI用于HCC筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Retrospective studies report that visualisation of the liver may be severely limited using ultrasound (US), potentially contributing to diminished sensitivity for detection of hepatocellular carcinoma (HCC) among patients with nonalcoholic fatty liver disease (NAFLD) and cirrhosis, but there are limited prospective data. AIMS: To compare liver visualisation scores prospectively for US and abbreviated hepatobiliary phase (HBP) magnetic resonance imaging (AMRI) in a cohort of participants with NAFLD cirrhosis and a clinical indication for HCC surveillance. METHODS: This prospective multicenter study included 54 consecutive participants (67% women) with NAFLD cirrhosis who underwent contemporaneous US as well as HBP-AMRI with gadoxetic acid. Primary outcome was the proportion of imaging examinations with severe limitations in liver visualisation (visualisation score C) compared head-to-head between US and AMRI. RESULTS: The mean (± standard deviation) age was 63.3 years (±8.4) and body mass index was 32.0 kg/m2 (±6.0). Nineteen participants (35%) had severe visualisation limitations on US, compared with 10 (19%) with AMRI, p < 0.0001. Nine (17%) participants had <90% of the liver visualised on US, compared with only 1 (2%) participant with AMRI, p < 0.0001. Obesity was a strong and independent predictor for severe visualisation limitation on US (OR 5.1, CI 1.1-23.1, p = 0.03), after adjustment for age, sex and ethnicity. CONCLUSION: More than one-third of participants with NAFLD cirrhosis had severe visualisation limitations on US for HCC screening, compared with one-sixth on AMRI. US adequacy should be reported in all clinical studies and when suboptimal then AMRI may be considered for HCC screening.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Huang DQ, Fowler KJ, Liau J, et al. Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study. Aliment Pharmacol Ther. 2022. PMID: 35229334. doi:10.1111/apt.16844

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。